ICON (ICLR) has drawn investor attention after recent share performance left the stock down about 13% year to date and roughly 10% lower over the past year, which has sharpened focus on valuation and fundamentals.
The recent drift lower continues a pattern for ICON, with the share price down over the year even after a modest 7 day rebound. The 1 year total shareholder return has also declined, signalling fading momentum as investors reassess the balance between growth prospects and risk.
Scan how ICON compares with a hand picked group of high quality value ideas by reviewing the 30 high quality undervalued stocks alongside this stock's recent pullback.
ICON now trades at a clear gap to both analyst targets and one intrinsic value estimate, so the real puzzle is how far that discount runs and which anchor investors should treat as fair.
ICON is framed as undervalued in the most followed narrative, with a fair value of $186.76 against the last close at $164.17, which centers the debate on whether earnings and margins can grow into that gap.
The main factor that has to go right is that ICON converts strong net book-to-bill momentum and new AI and lab investments into healthier direct fee growth and a gradual rebuild of adjusted EBITDA margins, despite mix pressure from pass-throughs and FSP work.
The current valuation suggests the market is treating ICON as fairly valued, with a cautious but constructive view that accounting issues are contained, capital returns via buybacks will resume, and AI and capacity investments can support earnings over time.
See why 13 investors see ICON as 12% undervalued.
Result: Fair Value of $186.76 (UNDERVALUED)
Still, the ICON story carries clear pressure points, including compressed adjusted EBITDA margins and unresolved investor concerns after the February 2026 accounting investigation and control weaknesses.
Find out about the key risks to this ICON narrative.
Mixed messages around ICON can create plenty of noise, so move quickly, test the numbers yourself, and weigh the 3 key rewards and 2 important warning signs.
Do not stop your research at ICON alone. Broaden your watchlist with fresh angles on quality, risk, and income so you are not missing stronger fits.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com